Radiopharm Theranostics RADX
NASDAQ RADX
$1.42 -0.06 (-4.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Other Accumulated Expenses (2024 - 2026)

Updated

Radiopharm Theranostics' Other Accumulated Expenses was $654,427 in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 3.6% from $631,898 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Other Accumulated Expenses at Radiopharm Theranostics came in at $626,572, down 0.8% from FY2025.

  • In earlier fiscal years, Other Accumulated Expenses was $631,898 in FY2025 (+286.2%) and $163,637 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Radiopharm Theranostics 5.03 Bn 5.00 Bn 186,835.86
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 654,427.38
Jun 30, 2025 631,898.15
Dec 31, 2024 16,635.00
Jun 30, 2024 163,637.10
API Access

Radiopharm Theranostics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RADX&period=max&api_key=YOUR_API_KEY